» Articles » PMID: 23922244

Temporal Dynamics of Clonal Evolution in Chronic Lymphocytic Leukemia with Stereotyped IGHV4-34/IGKV2-30 Antigen Receptors: Longitudinal Immunogenetic Evidence

Overview
Journal Mol Med
Publisher Biomed Central
Date 2013 Aug 8
PMID 23922244
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic lymphocytic leukemia (CLL) patients assigned to stereotyped subset 4 possess distinctive patterns of intraclonal diversification (ID) within their immunoglobulin (IG) genes. Although highly indicative of an ongoing response to antigen(s), the critical question concerning the precise timing of antigen involvement is unresolved. Hence, we conducted a large-scale longitudinal study of eight subset 4 cases totaling 511 and 398 subcloned IG heavy and kappa sequences. Importantly, we could establish a hierarchical pattern of subclonal evolution, thus revealing which somatic hypermutations were negatively or positively selected. In addition, distinct clusters of subcloned sequences with cluster-specific mutational profiles were observed initially; however, at later time points, the minor cluster had often disappeared and hence not been selected. Despite the high intensity of ID, it was remarkable that certain residues remained essentially unaltered. These novel findings strongly support a role for persistent antigen stimulation in the clonal evolution of CLL subset 4.

Citing Articles

Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements.

Vardi A, Vlachonikola E, Karypidou M, Stalika E, Bikos V, Gemenetzi K Leukemia. 2016; 31(7):1555-1561.

PMID: 27904140 DOI: 10.1038/leu.2016.362.


Antigen receptor stereotypy in chronic lymphocytic leukemia.

Stamatopoulos K, Agathangelidis A, Rosenquist R, Ghia P Leukemia. 2016; 31(2):282-291.

PMID: 27811850 DOI: 10.1038/leu.2016.322.


An entity evolving into a community: defining the common ancestor and evolutionary trajectory of chronic lymphocytic leukemia stereotyped subset #4.

Sutton L, Papadopoulos G, Hadzidimitriou A, Papadopoulos S, Kostareli E, Rosenquist R Mol Med. 2014; 20:720-8.

PMID: 25486132 PMC: 4398667. DOI: 10.2119/molmed.2014.00140.

References
1.
Silverman G, Cappione A, Villano M, Ryan D, Insel R, Sanz I . Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest. 2001; 108(7):1061-70. PMC: 200949. DOI: 10.1172/JCI12462. View

2.
Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stella S, Guida G . Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood. 2004; 105(4):1678-85. DOI: 10.1182/blood-2004-07-2606. View

3.
Lanemo Myhrinder A, Hellqvist E, Sidorova E, Soderberg A, Baxendale H, Dahle C . A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood. 2008; 111(7):3838-48. DOI: 10.1182/blood-2007-11-125450. View

4.
Messmer B, Albesiano E, Efremov D, Ghiotto F, Allen S, Kolitz J . Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med. 2004; 200(4):519-25. PMC: 2211936. DOI: 10.1084/jem.20040544. View

5.
Hashimoto S, Dono M, Wakai M, Allen S, Lichtman S, SCHULMAN P . Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med. 1995; 181(4):1507-17. PMC: 2191964. DOI: 10.1084/jem.181.4.1507. View